Journal ArticleOPEN ACCESS

Synthetic transdermal cannabidiol for the treatment of knee pain due to osteoarthritis

  • Hunter D
  • Oldfield G
  • Tich N
  • et al.
Osteoarthritis and Cartilage (2018) 26 S26
DOI: 10.1016/j.joca.2018.02.067
N/ACitations
Citations of this article
67Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cannabidiol (CBD) has shown promise in reducing pain and inflammation in pre-clinical models of arthritis. However, there have been no well controlled studies evaluating CBD for osteoarthritis (OA) in humans. This study evaluated safety and efficacy of ZYN002 (trans- dermal synthetic CBD gel) for the treatment of knee pain due to OA in adults.

Cite

CITATION STYLE

APA

Hunter, D., Oldfield, G., Tich, N., Messenheimer, J., & Sebree, T. (2018). Synthetic transdermal cannabidiol for the treatment of knee pain due to osteoarthritis. Osteoarthritis and Cartilage, 26, S26. https://doi.org/10.1016/j.joca.2018.02.067

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free